A Rody Selected Research

A Rody Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 04/2020 - 08/2004
13	Neoplasms (Cancer) 01/2020 - 08/2004
4	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 06/2006
3	Carcinoma (Carcinomatosis) 11/2012 - 08/2005
2	Ovarian Neoplasms (Ovarian Cancer) 05/2021 - 10/2006
2	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 10/2006
2	Inflammation (Inflammations) 06/2008 - 01/2003
2	Fibrosis (Cirrhosis) 06/2006 - 01/2003
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Ovarian Epithelial Carcinoma 12/2021
1	Hyperglycemia 12/2021
1	Neutropenia 12/2021
1	Arthralgia (Joint Pain) 04/2020
1	Musculoskeletal Pain 04/2020
1	Myalgia 04/2020
1	Pain (Aches) 04/2020
1	Triple Negative Breast Neoplasms 11/2012
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Infections 01/2008
1	Catheter-Related Infections 01/2008
1	Margins of Excision 12/2006
1	Bites and Stings (Sting) 10/2006
1	Endometriosis 06/2006
1	Pre-Eclampsia (Preeclampsia) 06/2006
1	Contracture 06/2006
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2004
1	Neoplasm Micrometastasis 08/2004
1	Wounds and Injuries (Trauma) 01/2003
1	Ovarian Torsion 02/2002

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 09/2010 - 12/2005
3	Capsules (Microcapsules)IBA 06/2008 - 01/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2007 - 04/2006
3	Docetaxel (Taxotere)FDA Link 06/2007 - 04/2006
2	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 10/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 10/2006
2	SphingolipidsIBA 05/2021 - 12/2009
2	EnzymesIBA 05/2021 - 12/2009
2	Aromatase InhibitorsIBA 04/2020 - 04/2005
2	Phenobarbital (Luminal)FDA Link 11/2012 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 11/2012 - 07/2008
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2009 - 02/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2007 - 02/2007
1	ganitumabIBA 12/2021
1	Insulin-Like PeptidesIBA 12/2021
1	ParaffinIBA 05/2021
1	Formaldehyde (Formol)FDA Link 05/2021
1	Letrozole (Femara)FDA LinkGeneric 04/2020
1	ThymosinIBA 11/2012
1	OsteopontinIBA 09/2010
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 09/2010
1	Epidermal Growth Factor (EGF)IBA 09/2010
1	InterferonsIBA 02/2010
1	Thymidine PhosphorylaseIBA 02/2010
1	Estrogens (Estrogen)FDA Link 12/2009
1	CeramidesIBA 12/2009
1	SphingosineIBA 12/2009
1	Acid CeramidaseIBA 12/2009
1	Estrogen ReceptorsIBA 02/2009
1	CD100 antigenIBA 07/2008
1	plexinIBA 07/2008
1	Semaphorins (Semaphorin)IBA 07/2008
1	Biological ProductsIBA 07/2008
1	Cell Surface ReceptorsIBA 07/2008
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2008
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2008
1	Warfarin (Coumadin)FDA LinkGeneric 01/2008
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2007
1	Trastuzumab (Herceptin)FDA Link 10/2006
1	Lapatinib (GW572016)FDA Link 10/2006
1	Bevacizumab (Avastin)FDA Link 10/2006
1	Taxoids (Taxanes)IBA 10/2006
1	Cytotoxins (Cytolysins)IBA 10/2006
1	IntegrinsIBA 06/2006
1	Complementary DNA (cDNA)IBA 06/2006
1	Integrin alphaVIBA 06/2006
1	Estrogen Receptor betaIBA 12/2005
1	HydrogelsIBA 01/2003
1	SiliconesIBA 01/2003

Therapy/Procedure

11	Therapeutics 04/2020 - 08/2004
5	Drug Therapy (Chemotherapy) 12/2021 - 08/2004
3	Neoadjuvant Therapy 11/2012 - 02/2007
1	Complementary Therapies (Alternative Medicine) 04/2020
1	Laparotomy 01/2020
1	Morcellation 01/2020
1	Hysterectomy 01/2019
1	Critical Care (Surgical Intensive Care) 01/2008
1	Radiotherapy 06/2006
1	Breast Implants (Breast Implant) 06/2006
1	Lymph Node Excision (Lymph Node Dissection) 08/2004
1	Conservative Treatment 02/2002